Icon (Close Menu)


Little Rock’s RxResults Raises $4M Investment Round

1 min read

RxResults, a pharmacy risk management company based in Little Rock, on Wednesday announced a $4 million investment by Ansley Equity Partners and Ansley Equities of Naperville, Ill.

RxResults, an Innovate Arkansas and Arkansas Science & Technology Authority client firm, provides evidence-based management programs in the areas of formulary management, medication therapy management, specialty drug management and prescriber profiling.

Created in the BioVentures incubator at the University of Arkansas for Medical Sciences, RxResults collaborates with the UAMS College of Pharmacy and its evidence-based medicine center.

RxResults CEO Tery Baskin said the funding round will be used to accelerate company growth and expand service offerings.

“This capital raise is a confirmation and endorsement that after nearly a decade of R&D, RxResults has successfully commercialized a suite of proprietary solutions offering clients an impressive return on investment while improving the health status of covered members,” he said.

Send this to a friend